Abstract
Patients with relapsed low-grade follicular lymphomas (LGFL) frequently respond to subsequent therapy and can have long survival, but are rarely cured. Factors associated with complete remission (CR) rate, length of survival, and time to treatment failure (TTF) after relapse are not well known. We assessed such factors by multivariate analysis in a retrospective review of 95 patients with relapsed LGFL treated with investigational chemotherapy regimens at our institution. The CR rate after therapy was 22%; the likelihood of achieving CR was inversely associated with the number of previous treatment failures (P < 0.001) and serum.
Original language | English (US) |
---|---|
Pages (from-to) | 227-232 |
Number of pages | 6 |
Journal | Annals of Oncology |
Volume | 3 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1992 |
ASJC Scopus subject areas
- Hematology
- Oncology